Published in Healthcare Finance, Tax and Law Weekly, March 16th, 2005
Net income for the 3 months ended December 31, 2004, was $56.6 million and $0.56 per share. Net income for the year ended December 31, 2004, was $217.2 million, and $2.11 per share, excluding after-tax Medicare lab recoveries of $5.1 million.
Net income for the year ended December 31, 2004, including the lab recoveries (generally accepted accounting principles basis), was $222.3 million and $2.16 per share.
Cash flow for the 12 months ended December 31, 2004, was the company's strongest ever with operating cash flow and free cash flow of $361...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.